A variety of novel thiazolidine derivatives (2-thioxothiazolidin-4-one and thiazolidine-2, 4-dione derivatives) have been prepared by using 2,4-diphenyl-2H-chromene-3-carbaldehyde and its derivatives as starting materials. This is the first example of the preparation of thiazolidine derivatives through this novel method. Structure evolution of the resulting thiazolidine derivatives leads to anticancer agents. . In recent years, the push-pull effects of thiazolidinone derivatives have received the special interest of physicists and chemists for their nonlinear optical properties [5] . Previously, it was shown that the presence and nature of the thiazolidinone moiety plays a key role in the biological and physical properties [6]. We focus now on the synthesis and cytotoxicity of novel 2H-chromene derivatives bearing thiazolidine-2, 4-dione moieties (Scheme 1).
A diverse range of azolidinone heterocyclic compounds, particularly thiazolidin-4 one derivatives [1] , has been widely investigated for their pharmacological properties such as antiviral, anticonvulsant [2] , antibacterial [3] , hypolipidaemic, anti-inflammatory and potential anticancer activities [4] . In recent years, the push-pull effects of thiazolidinone derivatives have received the special interest of physicists and chemists for their nonlinear optical properties [5] . Previously, it was shown that the presence and nature of the thiazolidinone moiety plays a key role in the biological and physical properties [6] . We focus now on the synthesis and cytotoxicity of novel 2H-chromene derivatives bearing thiazolidine-2, 4-dione moieties (Scheme 1).
Scheme 1: Synthesis of novel 2-thioxothiazolidin-4-one and thiazolidine-2, 4-dione derivatives.
The syntheses of (Z)-5-{(2, 4-diaryl-2H-chromen-3-yl) methylene}-2-thioxothiazolidin-4-ones (4a-h) has been carried out using a twostep sequence, as follows (Scheme 2): (1) The reaction between the 4-chloro-2-aryl-2H-chromene-3-carbaldehyde [7] (1a-b) and aryl boronic acid (2a-b) derivatives gave new 2,4-diphenyl-2H-chromene-3-carbaldehydes (3a-d); (2) 2-Thioxothiazolidin-4-one reacts with 3a-d to yield (Z)-5-{(2, 4-diphenyl-2H-chromen-3-yl) methylene}-2-thioxothiazolidin-4-ones (4a-h). The structures of all new compounds were determined by different spectroscopic methods (FT-IR, 1 H NMR, 13 C NMR and MS) (Scheme 1).
The reaction proceeds smoothly via a tandem Knoevenagel pathway and is highly diastereoselective affording exclusively cis-fused chromene derivatives. We then turned our attention to thiazolidinone and substituted 2, 4-diphenyl-2H-chromene-3-carbaldehyde. Interestingly, a variety of thiazolidinone derivatives participated well in this reaction. The reaction was also quite successful with p-methoxy-2, 4-diphenyl-2H-chromene-3-carbaldehyde. Irrespective of the electronic and steric effects, the reaction proceeds well under the present conditions. Therefore, steric and electronic factors did not show any recognizable effects on the rate of reaction (Scheme 2). In order to study possible bioactivity, some of the selected chromene analogs were tested for their in vitro cytotoxicity to the human alveolar epithelial cell line (A549) and mouse macrophage cells (B-16). The cytotoxicity of the test compounds to the cells was determined by the MTT [3-(4, 5-dimethylthaizol-2-yl)-2, 5-diphenyl tetrazolium bromide] assay [8] .
In general, most of the tested compounds showed moderate to strong cytotoxicity to the above two cell lines. Among the tested compounds, 4f showed the most potent cytotoxicity to A549 with an IC 50 value of 0.28 μg/mL ( Table 2 , entry 6); compound 4e exhibited the strongest cytotoxicity to the B-16 cell line with an IC 50 value of 2.0 μg/mL ( Table 2 , entry 5). It is noteworthy that the 2H-chromene analog 4e also showed marked cytotoxicity to the A549 cell line with an IC 50 value of 4.0 μg/mL. Therefore, these chromene derivatives may become promising antitumor drug candidates for further pharmacological studies.
In conclusion, we have demonstrated a route for the synthesis of novel chromene derivatives by means of a Knoevenagel condensation of chromene-3-carboxaldehyde derivatives with 2-thioxo-4-thiazolidinone and 2, 4-thiazolidinedione derivatives. The method is diastereoselective leading to cis-annulated heterocycles in a single-step process. Some of these molecules were found to possess potent cytotoxicity against two carcinoma cell lines. We believe that these chromenes may find medicinal application after structural modification and further biological studies.
Experimental

General:
The purity of the compounds was checked by TLC on silica gel F254 (Merck). All the reagents and solvents were reagent grade and were used without further purification. Melting points were determined in open capillaries and are uncorrected. IR spectra were taken on a Shimadzu FTIR 8400S spectrophotometer. NMR spectra were registered on a Bruker Avance II 400 MHz spectrometer and mass spectra were recorded on a Shimadzu mass spectrometer. Elemental analysis was performed by using a Thermo Finnigan CHNS analyzer.
General procedure for synthesis of 2, 4-diaryl-2H-chromene-3-carbaldehyde (3a-b):
In a two-necked flask under an atmosphere of nitrogen was placed the correct amount of catalyst from a stock solution (made by mixing PdCl 2 (PPh 3 ) 4 and 1 in dioxane). After drying under vacuum, 5 mL of toluene was added to the flask. After stirring for 5 min, 4-chloro-2-phenyl-2H-chromene-3-carbaldehyde (0.5 mmol), aryl boronic acid (0.75 mmol) and K 2 CO 3 ( 1 mmol) were added. The mixture was then stirred at either room temperature or at the required temperature for 2 h. The solvent was then removed under reduced pressure. The resultant residual mixture was diluted with water (10 mL) and Et 2 O (10 mL), followed by extraction twice (2 × 6 mL) with Et 2 O. The combined organic fraction was dried over MgSO 4 . The solid residue was purified by CC on silica gel (60-120 mesh) with an eluent of nhexane/EtOAc to give the compound in 90% yield.
2, 4-Diphenyl-2H-chromene-3-carbaldehyde (3a)
Yield General procedure for synthesis of (Z)-5-((2, 4-diphenyl-2H-chromen-3-yl) methylene) thiazolidine-2, 4-dione (4a-h): 2-Thioxothiazolidin-4-one (5a-b) (1 mmol) and the appropriate 2, 4-diphenyl-2H-chromene-3-carbaldehyde (3a-d) (1 mmol) were dissolved in ethanol (5 mL). The solution was refluxed for 1 to 2 h Novel 2-thioxothiazolidin-4-one and thiazolidine-2, 4-dione derivatives Natural Product Communications Vol. 13 (5) 2018 591 in the presence of a 10 mol% of pyrrolidine as a catalyst. After completion of the reaction (monitored by TLC), the mixture was cooled, the precipitate removed by filtration, and crystallized from ethanol to give the corresponding product. 
(Z)-5-{(2, 4-diphenyl-2H-chromen-3-yl) methylene}-2-thioxo
